Evgenia Dobrinskikh
Concepts (351)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucin-5B | 9 | 2023 | 185 | 2.580 |
Why?
| Idiopathic Pulmonary Fibrosis | 11 | 2023 | 511 | 2.060 |
Why?
| Hernias, Diaphragmatic, Congenital | 3 | 2020 | 187 | 1.620 |
Why?
| Lung | 10 | 2022 | 3673 | 1.600 |
Why?
| Lung Injury | 3 | 2021 | 199 | 1.440 |
Why?
| Acetaminophen | 3 | 2022 | 237 | 1.420 |
Why?
| Fetus | 2 | 2020 | 702 | 1.000 |
Why?
| Bleomycin | 5 | 2023 | 232 | 0.990 |
Why?
| Endocytosis | 4 | 2014 | 152 | 0.900 |
Why?
| Podocytes | 6 | 2019 | 44 | 0.820 |
Why?
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 2 | 2013 | 9 | 0.800 |
Why?
| Respiratory Mucosa | 2 | 2021 | 258 | 0.790 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2021 | 274 | 0.780 |
Why?
| Kidney Tubules, Proximal | 2 | 2013 | 113 | 0.740 |
Why?
| Idiopathic Interstitial Pneumonias | 1 | 2020 | 48 | 0.700 |
Why?
| Therapeutic Occlusion | 1 | 2020 | 3 | 0.700 |
Why?
| Fetal Therapies | 1 | 2020 | 30 | 0.680 |
Why?
| Glycolysis | 4 | 2021 | 224 | 0.660 |
Why?
| Animals | 38 | 2024 | 32104 | 0.630 |
Why?
| Organogenesis | 1 | 2019 | 54 | 0.630 |
Why?
| Serum Albumin | 3 | 2019 | 135 | 0.620 |
Why?
| Tracheal Stenosis | 1 | 2018 | 24 | 0.610 |
Why?
| Nerve Tissue Proteins | 2 | 2013 | 535 | 0.600 |
Why?
| Liver | 4 | 2023 | 1690 | 0.580 |
Why?
| Airway Obstruction | 1 | 2019 | 168 | 0.560 |
Why?
| Fluorescein-5-isothiocyanate | 3 | 2014 | 37 | 0.520 |
Why?
| Oxidative Phosphorylation | 3 | 2021 | 156 | 0.490 |
Why?
| Gene Expression Regulation | 4 | 2021 | 2353 | 0.490 |
Why?
| Mice | 21 | 2024 | 15052 | 0.470 |
Why?
| Caveolae | 1 | 2014 | 16 | 0.470 |
Why?
| Disease Models, Animal | 9 | 2022 | 3580 | 0.460 |
Why?
| Rabbits | 3 | 2020 | 752 | 0.440 |
Why?
| Receptors, G-Protein-Coupled | 4 | 2022 | 192 | 0.410 |
Why?
| Cytochrome P-450 CYP2E1 | 2 | 2021 | 27 | 0.390 |
Why?
| Kidney | 4 | 2019 | 1207 | 0.360 |
Why?
| Cysts | 2 | 2022 | 93 | 0.350 |
Why?
| Diabetic Nephropathies | 3 | 2017 | 234 | 0.340 |
Why?
| Non-alcoholic Fatty Liver Disease | 2 | 2023 | 246 | 0.330 |
Why?
| Optical Imaging | 2 | 2021 | 55 | 0.320 |
Why?
| Pulmonary Surfactants | 2 | 2020 | 101 | 0.320 |
Why?
| Lysosomes | 3 | 2014 | 125 | 0.310 |
Why?
| Diet, Western | 3 | 2023 | 66 | 0.300 |
Why?
| Extracellular Matrix | 2 | 2021 | 439 | 0.300 |
Why?
| Hepacivirus | 3 | 2015 | 234 | 0.290 |
Why?
| Trachea | 2 | 2020 | 233 | 0.290 |
Why?
| Signal Transduction | 10 | 2022 | 4541 | 0.280 |
Why?
| Intestinal Mucosa | 3 | 2017 | 528 | 0.270 |
Why?
| Receptors, Fc | 2 | 2019 | 45 | 0.270 |
Why?
| Vero Cells | 1 | 2006 | 65 | 0.260 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2017 | 195 | 0.260 |
Why?
| Pseudopodia | 1 | 2006 | 20 | 0.260 |
Why?
| Microglia | 2 | 2024 | 203 | 0.240 |
Why?
| Endoplasmic Reticulum Stress | 2 | 2023 | 92 | 0.240 |
Why?
| Metabolomics | 2 | 2020 | 538 | 0.240 |
Why?
| Microtubules | 1 | 2006 | 238 | 0.220 |
Why?
| Pregnancy | 6 | 2022 | 5553 | 0.220 |
Why?
| Fibrosis | 6 | 2023 | 457 | 0.220 |
Why?
| Cell Line | 5 | 2017 | 2651 | 0.220 |
Why?
| Eukaryotic Initiation Factor-2B | 1 | 2023 | 5 | 0.220 |
Why?
| Sirtuin 3 | 1 | 2023 | 52 | 0.210 |
Why?
| Microscopy, Fluorescence | 2 | 2016 | 402 | 0.210 |
Why?
| Saccharopolyspora | 1 | 2022 | 6 | 0.210 |
Why?
| Kidney Diseases | 2 | 2017 | 354 | 0.210 |
Why?
| Humans | 34 | 2024 | 115741 | 0.210 |
Why?
| Diabetes Mellitus, Experimental | 3 | 2019 | 161 | 0.210 |
Why?
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 29 | 0.200 |
Why?
| Endotoxemia | 1 | 2023 | 84 | 0.200 |
Why?
| Gain of Function Mutation | 2 | 2018 | 31 | 0.200 |
Why?
| Bile Acids and Salts | 3 | 2017 | 172 | 0.200 |
Why?
| Bone Marrow | 1 | 2023 | 249 | 0.190 |
Why?
| Ductus Arteriosus, Patent | 1 | 2022 | 50 | 0.190 |
Why?
| Assisted Circulation | 1 | 2021 | 25 | 0.190 |
Why?
| Rats | 6 | 2019 | 5033 | 0.190 |
Why?
| Cell Movement | 1 | 2006 | 867 | 0.190 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2022 | 92 | 0.190 |
Why?
| Mice, Inbred ICR | 1 | 2021 | 111 | 0.190 |
Why?
| Heart Murmurs | 1 | 2021 | 11 | 0.190 |
Why?
| Fatty Acids, Omega-3 | 1 | 2022 | 124 | 0.190 |
Why?
| Phosphates | 2 | 2013 | 160 | 0.180 |
Why?
| Male | 15 | 2024 | 56050 | 0.180 |
Why?
| Epithelium | 1 | 2021 | 297 | 0.180 |
Why?
| Kidney Tubules | 2 | 2019 | 107 | 0.180 |
Why?
| Female | 16 | 2024 | 60018 | 0.180 |
Why?
| Hepatitis C | 2 | 2015 | 229 | 0.180 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2021 | 141 | 0.180 |
Why?
| Aortic Diseases | 1 | 2021 | 111 | 0.180 |
Why?
| Neurodegenerative Diseases | 1 | 2021 | 92 | 0.180 |
Why?
| Hematopoietic Stem Cells | 1 | 2023 | 346 | 0.170 |
Why?
| Liver Cirrhosis | 1 | 2021 | 238 | 0.170 |
Why?
| Cellular Senescence | 1 | 2021 | 153 | 0.170 |
Why?
| Cholic Acids | 2 | 2017 | 17 | 0.170 |
Why?
| Genetic Predisposition to Disease | 4 | 2022 | 2129 | 0.170 |
Why?
| Biomarkers | 3 | 2021 | 3471 | 0.170 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2021 | 199 | 0.170 |
Why?
| NF-kappa B | 1 | 2023 | 639 | 0.170 |
Why?
| Orthomyxoviridae Infections | 1 | 2019 | 55 | 0.160 |
Why?
| Molecular Imaging | 1 | 2019 | 52 | 0.160 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 139 | 0.160 |
Why?
| Telomere | 1 | 2021 | 204 | 0.160 |
Why?
| Ventricular Remodeling | 1 | 2021 | 227 | 0.160 |
Why?
| Lipoxygenase Inhibitors | 1 | 2019 | 36 | 0.160 |
Why?
| Rats, Sprague-Dawley | 3 | 2014 | 2262 | 0.160 |
Why?
| Alzheimer Disease | 1 | 2024 | 438 | 0.160 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 301 | 0.160 |
Why?
| Mucociliary Clearance | 1 | 2018 | 42 | 0.160 |
Why?
| Lipid Metabolism | 2 | 2022 | 449 | 0.150 |
Why?
| Organ Size | 1 | 2019 | 434 | 0.150 |
Why?
| Desoxycorticosterone Acetate | 1 | 2017 | 3 | 0.150 |
Why?
| Mice, Inbred C57BL | 7 | 2023 | 4773 | 0.150 |
Why?
| Relaxin | 1 | 2017 | 15 | 0.150 |
Why?
| Histocompatibility Antigens Class I | 1 | 2019 | 174 | 0.150 |
Why?
| Primates | 3 | 2023 | 111 | 0.150 |
Why?
| 5'-Nucleotidase | 1 | 2017 | 33 | 0.150 |
Why?
| Arrhythmias, Cardiac | 1 | 2020 | 279 | 0.150 |
Why?
| Nanotubes, Carbon | 1 | 2017 | 43 | 0.140 |
Why?
| Gangliosides | 1 | 2017 | 19 | 0.140 |
Why?
| Salmonella enterica | 1 | 2017 | 51 | 0.140 |
Why?
| Membrane Microdomains | 1 | 2017 | 32 | 0.140 |
Why?
| Glucuronidase | 1 | 2017 | 42 | 0.140 |
Why?
| Protein Transport | 2 | 2019 | 400 | 0.140 |
Why?
| Cardiomyopathy, Dilated | 1 | 2020 | 352 | 0.140 |
Why?
| Nephrosclerosis | 1 | 2016 | 6 | 0.140 |
Why?
| Proteolysis | 2 | 2014 | 145 | 0.140 |
Why?
| Cell Polarity | 2 | 2014 | 131 | 0.130 |
Why?
| Obesity | 3 | 2019 | 2518 | 0.130 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2020 | 449 | 0.130 |
Why?
| Myocardium | 2 | 2020 | 926 | 0.130 |
Why?
| Adenosine | 1 | 2017 | 203 | 0.130 |
Why?
| Immunity, Maternally-Acquired | 1 | 2015 | 22 | 0.130 |
Why?
| Heart-Assist Devices | 1 | 2021 | 486 | 0.130 |
Why?
| Lung Diseases | 1 | 2022 | 710 | 0.130 |
Why?
| Epithelial Cells | 3 | 2018 | 961 | 0.130 |
Why?
| Renal Insufficiency | 1 | 2017 | 137 | 0.130 |
Why?
| Claudin-1 | 1 | 2015 | 21 | 0.130 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 350 | 0.120 |
Why?
| Immunoglobulin G | 1 | 2019 | 781 | 0.120 |
Why?
| Clathrin | 2 | 2014 | 27 | 0.120 |
Why?
| Aging | 3 | 2024 | 1632 | 0.120 |
Why?
| Hypoxia-Inducible Factor 1 | 1 | 2015 | 68 | 0.120 |
Why?
| Host-Pathogen Interactions | 1 | 2017 | 296 | 0.120 |
Why?
| Autocrine Communication | 1 | 2014 | 43 | 0.120 |
Why?
| Tight Junctions | 1 | 2015 | 68 | 0.120 |
Why?
| Transcriptome | 1 | 2020 | 736 | 0.120 |
Why?
| Colitis | 2 | 2013 | 226 | 0.120 |
Why?
| Transcytosis | 1 | 2014 | 9 | 0.120 |
Why?
| Microvilli | 2 | 2012 | 70 | 0.120 |
Why?
| Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 5 | 0.120 |
Why?
| Immunity, Innate | 4 | 2023 | 731 | 0.110 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 15 | 0.110 |
Why?
| Albumins | 1 | 2014 | 91 | 0.110 |
Why?
| Trophoblasts | 1 | 2015 | 162 | 0.110 |
Why?
| Brain | 2 | 2024 | 2373 | 0.110 |
Why?
| Creatine Kinase | 1 | 2013 | 72 | 0.110 |
Why?
| Interferons | 1 | 2014 | 152 | 0.110 |
Why?
| Creatine | 1 | 2013 | 51 | 0.110 |
Why?
| Heart | 1 | 2017 | 610 | 0.110 |
Why?
| Exosomes | 1 | 2014 | 92 | 0.110 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 488 | 0.110 |
Why?
| Protease Inhibitors | 1 | 2014 | 101 | 0.110 |
Why?
| Didelphis | 1 | 2013 | 3 | 0.110 |
Why?
| Vesicular Transport Proteins | 1 | 2014 | 83 | 0.110 |
Why?
| Lung Diseases, Interstitial | 1 | 2018 | 520 | 0.110 |
Why?
| Interferon-gamma | 2 | 2013 | 726 | 0.110 |
Why?
| Cell Hypoxia | 1 | 2013 | 220 | 0.110 |
Why?
| Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2012 | 9 | 0.100 |
Why?
| Enterocytes | 1 | 2012 | 14 | 0.100 |
Why?
| Sodium-Hydrogen Exchangers | 1 | 2012 | 20 | 0.100 |
Why?
| Hypertension, Pulmonary | 1 | 2023 | 1754 | 0.100 |
Why?
| Killer Cells, Natural | 1 | 2015 | 383 | 0.100 |
Why?
| Virus Replication | 1 | 2014 | 396 | 0.100 |
Why?
| Interleukin-10 | 1 | 2013 | 299 | 0.100 |
Why?
| Pregnancy Complications, Infectious | 1 | 2015 | 289 | 0.100 |
Why?
| RNA, Messenger | 4 | 2021 | 2574 | 0.100 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 176 | 0.090 |
Why?
| Green Fluorescent Proteins | 1 | 2013 | 377 | 0.090 |
Why?
| RNA Interference | 1 | 2013 | 438 | 0.090 |
Why?
| Mice, Knockout | 4 | 2019 | 2604 | 0.090 |
Why?
| Phosphorus, Dietary | 1 | 2010 | 4 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2021 | 3122 | 0.090 |
Why?
| Kidney Cortex | 1 | 2010 | 23 | 0.090 |
Why?
| Glomerular Filtration Rate | 1 | 2014 | 606 | 0.090 |
Why?
| RNA, Small Interfering | 1 | 2013 | 544 | 0.090 |
Why?
| Kinetics | 1 | 2014 | 1569 | 0.090 |
Why?
| Phosphoproteins | 1 | 2012 | 304 | 0.090 |
Why?
| Arthritis, Rheumatoid | 1 | 2018 | 1003 | 0.090 |
Why?
| Mitochondria | 3 | 2023 | 750 | 0.090 |
Why?
| Galectins | 1 | 2010 | 22 | 0.090 |
Why?
| Kupffer Cells | 1 | 2010 | 45 | 0.090 |
Why?
| Sequence Analysis, RNA | 2 | 2022 | 391 | 0.080 |
Why?
| Gene Expression Regulation, Viral | 1 | 2010 | 80 | 0.080 |
Why?
| Endosomes | 1 | 2010 | 125 | 0.080 |
Why?
| Endothelial Cells | 1 | 2014 | 696 | 0.080 |
Why?
| Hypertension | 1 | 2017 | 1064 | 0.080 |
Why?
| Biophysical Phenomena | 2 | 2021 | 63 | 0.080 |
Why?
| Cell Membrane | 1 | 2013 | 683 | 0.080 |
Why?
| Promoter Regions, Genetic | 3 | 2018 | 1122 | 0.080 |
Why?
| Longevity | 2 | 2022 | 137 | 0.080 |
Why?
| Heart Failure | 1 | 2021 | 1964 | 0.080 |
Why?
| Cells, Cultured | 4 | 2019 | 3914 | 0.080 |
Why?
| Mice, Transgenic | 3 | 2019 | 1970 | 0.080 |
Why?
| Oxidative Stress | 3 | 2022 | 1093 | 0.080 |
Why?
| Fibroblasts | 2 | 2023 | 839 | 0.070 |
Why?
| Thiazolidines | 1 | 2006 | 7 | 0.070 |
Why?
| Nocodazole | 1 | 2006 | 17 | 0.070 |
Why?
| Diacetyl | 1 | 2006 | 7 | 0.070 |
Why?
| Inflammation | 3 | 2022 | 2500 | 0.060 |
Why?
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2006 | 171 | 0.060 |
Why?
| Middle Aged | 5 | 2024 | 27069 | 0.060 |
Why?
| Phenotype | 2 | 2023 | 2839 | 0.060 |
Why?
| NF-kappa B p50 Subunit | 1 | 2023 | 25 | 0.050 |
Why?
| NAD | 1 | 2023 | 67 | 0.050 |
Why?
| Receptors, Immunologic | 1 | 2024 | 203 | 0.050 |
Why?
| PQQ Cofactor | 1 | 2022 | 5 | 0.050 |
Why?
| HEK293 Cells | 2 | 2017 | 602 | 0.050 |
Why?
| Recombinant Proteins | 2 | 2017 | 1243 | 0.050 |
Why?
| PPAR alpha | 1 | 2022 | 52 | 0.050 |
Why?
| T-Lymphocytes | 1 | 2010 | 1756 | 0.050 |
Why?
| Matrix Metalloproteinases, Secreted | 1 | 2021 | 10 | 0.050 |
Why?
| Long Term Adverse Effects | 1 | 2021 | 10 | 0.050 |
Why?
| ADAMTS4 Protein | 1 | 2021 | 16 | 0.050 |
Why?
| Mitochondrial Proteins | 1 | 2023 | 219 | 0.050 |
Why?
| Tyrphostins | 1 | 2021 | 14 | 0.050 |
Why?
| Amphiregulin | 1 | 2021 | 21 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2024 | 431 | 0.050 |
Why?
| Estrogens | 1 | 2024 | 315 | 0.050 |
Why?
| Hedgehog Proteins | 1 | 2022 | 172 | 0.050 |
Why?
| Keratin-5 | 1 | 2021 | 46 | 0.050 |
Why?
| Cilia | 1 | 2022 | 162 | 0.050 |
Why?
| C-Reactive Protein | 1 | 2023 | 364 | 0.050 |
Why?
| Cattle | 1 | 2023 | 935 | 0.050 |
Why?
| Diet, High-Fat | 1 | 2022 | 225 | 0.050 |
Why?
| Substrate Specificity | 1 | 2021 | 357 | 0.050 |
Why?
| Quantitative Trait Loci | 1 | 2022 | 313 | 0.050 |
Why?
| Cohort Studies | 2 | 2021 | 4949 | 0.050 |
Why?
| Single-Cell Analysis | 1 | 2022 | 188 | 0.050 |
Why?
| Uterus | 1 | 2021 | 193 | 0.050 |
Why?
| Flow Cytometry | 2 | 2014 | 1083 | 0.040 |
Why?
| Maternal Exposure | 1 | 2021 | 138 | 0.040 |
Why?
| Vascular Remodeling | 1 | 2021 | 155 | 0.040 |
Why?
| Positron-Emission Tomography | 1 | 2021 | 284 | 0.040 |
Why?
| Keratin-15 | 1 | 2019 | 12 | 0.040 |
Why?
| Intensive Care Units, Neonatal | 1 | 2022 | 179 | 0.040 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2022 | 608 | 0.040 |
Why?
| Quinazolines | 1 | 2021 | 241 | 0.040 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2021 | 483 | 0.040 |
Why?
| Principal Component Analysis | 1 | 2020 | 178 | 0.040 |
Why?
| Colloids | 1 | 2019 | 58 | 0.040 |
Why?
| Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
| Antioxidants | 1 | 2023 | 533 | 0.040 |
Why?
| Aged | 3 | 2024 | 19294 | 0.040 |
Why?
| Expectorants | 1 | 2018 | 24 | 0.040 |
Why?
| Arachidonate 5-Lipoxygenase | 1 | 2019 | 45 | 0.040 |
Why?
| Transforming Growth Factor beta1 | 1 | 2020 | 156 | 0.040 |
Why?
| Pulmonary Surfactant-Associated Protein C | 1 | 2018 | 42 | 0.040 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 374 | 0.040 |
Why?
| Dietary Supplements | 1 | 2022 | 458 | 0.040 |
Why?
| DNA Methylation | 1 | 2022 | 499 | 0.040 |
Why?
| Kidney Glomerulus | 1 | 2019 | 102 | 0.040 |
Why?
| Cluster Analysis | 1 | 2020 | 465 | 0.040 |
Why?
| Polycystic Kidney Diseases | 1 | 2019 | 55 | 0.040 |
Why?
| Ureteral Obstruction | 1 | 2019 | 54 | 0.040 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 139 | 0.040 |
Why?
| ErbB Receptors | 1 | 2021 | 557 | 0.040 |
Why?
| Chenodeoxycholic Acid | 1 | 2017 | 12 | 0.040 |
Why?
| Glomerular Mesangium | 1 | 2017 | 17 | 0.040 |
Why?
| Nucleotidases | 1 | 2017 | 7 | 0.040 |
Why?
| Mitochondrial Turnover | 1 | 2017 | 4 | 0.040 |
Why?
| Collagen | 1 | 2020 | 416 | 0.040 |
Why?
| Mice, Inbred DBA | 1 | 2017 | 173 | 0.040 |
Why?
| Gene Expression | 1 | 2022 | 1436 | 0.040 |
Why?
| Bacterial Load | 1 | 2017 | 60 | 0.040 |
Why?
| Drug Administration Schedule | 1 | 2019 | 724 | 0.040 |
Why?
| Gelatin | 1 | 2017 | 36 | 0.040 |
Why?
| Heart Function Tests | 1 | 2017 | 59 | 0.040 |
Why?
| Urinalysis | 1 | 2017 | 62 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2021 | 1642 | 0.040 |
Why?
| Sodium-Glucose Transporter 2 | 1 | 2017 | 17 | 0.040 |
Why?
| Pancreas | 1 | 2019 | 280 | 0.040 |
Why?
| Kidney Function Tests | 1 | 2017 | 141 | 0.040 |
Why?
| Mice, Mutant Strains | 1 | 2017 | 271 | 0.030 |
Why?
| Albuminuria | 1 | 2017 | 164 | 0.030 |
Why?
| Hypolipidemic Agents | 1 | 2017 | 87 | 0.030 |
Why?
| RNA | 1 | 2022 | 820 | 0.030 |
Why?
| Caloric Restriction | 1 | 2017 | 90 | 0.030 |
Why?
| Salmonella typhimurium | 1 | 2017 | 161 | 0.030 |
Why?
| DNA | 1 | 2022 | 1356 | 0.030 |
Why?
| Cholesterol | 1 | 2017 | 369 | 0.030 |
Why?
| Odds Ratio | 1 | 2018 | 962 | 0.030 |
Why?
| Triglycerides | 1 | 2017 | 473 | 0.030 |
Why?
| Tissue Scaffolds | 1 | 2017 | 180 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2019 | 1870 | 0.030 |
Why?
| HeLa Cells | 1 | 2017 | 567 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2015 | 129 | 0.030 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 332 | 0.030 |
Why?
| Denys-Drash Syndrome | 1 | 2014 | 3 | 0.030 |
Why?
| WT1 Proteins | 1 | 2014 | 12 | 0.030 |
Why?
| Electrocardiography | 1 | 2017 | 564 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2017 | 479 | 0.030 |
Why?
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 7 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 2015 | 346 | 0.030 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 17 | 0.030 |
Why?
| Hydrogen Peroxide | 1 | 2015 | 287 | 0.030 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 2015 | 152 | 0.030 |
Why?
| Dextran Sulfate | 1 | 2013 | 70 | 0.030 |
Why?
| Neurons | 1 | 2021 | 1298 | 0.030 |
Why?
| Hepatocytes | 1 | 2014 | 197 | 0.030 |
Why?
| Transcription Factors | 1 | 2021 | 1528 | 0.030 |
Why?
| Genotype | 1 | 2018 | 1787 | 0.030 |
Why?
| Superoxide Dismutase | 1 | 2015 | 332 | 0.030 |
Why?
| Permeability | 1 | 2013 | 150 | 0.030 |
Why?
| Dextrans | 1 | 2013 | 74 | 0.030 |
Why?
| Tissue Engineering | 1 | 2017 | 366 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2013 | 154 | 0.030 |
Why?
| Myocytes, Cardiac | 1 | 2017 | 457 | 0.030 |
Why?
| Transcriptional Activation | 1 | 2015 | 340 | 0.030 |
Why?
| Interleukins | 1 | 2014 | 238 | 0.030 |
Why?
| Fluorescent Antibody Technique | 1 | 2013 | 398 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 302 | 0.030 |
Why?
| DNA Primers | 1 | 2013 | 514 | 0.030 |
Why?
| Caco-2 Cells | 1 | 2012 | 66 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2017 | 794 | 0.030 |
Why?
| STAT3 Transcription Factor | 1 | 2013 | 174 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2013 | 477 | 0.020 |
Why?
| Cytoskeletal Proteins | 1 | 2012 | 145 | 0.020 |
Why?
| Infant, Newborn | 1 | 2022 | 5061 | 0.020 |
Why?
| Repressor Proteins | 1 | 2014 | 369 | 0.020 |
Why?
| Blood Pressure | 1 | 2017 | 1539 | 0.020 |
Why?
| Blotting, Western | 1 | 2013 | 1153 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2013 | 1001 | 0.020 |
Why?
| Analysis of Variance | 1 | 2013 | 1230 | 0.020 |
Why?
| Disease Progression | 1 | 2017 | 2423 | 0.020 |
Why?
| Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 11 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2017 | 2751 | 0.020 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 66 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2012 | 804 | 0.020 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 388 | 0.020 |
Why?
| CD4 Antigens | 1 | 2010 | 124 | 0.020 |
Why?
| Forkhead Transcription Factors | 1 | 2010 | 171 | 0.020 |
Why?
| Carrier Proteins | 1 | 2012 | 701 | 0.020 |
Why?
| Risk Factors | 1 | 2021 | 8702 | 0.020 |
Why?
| Ligands | 1 | 2010 | 569 | 0.020 |
Why?
| Adult | 2 | 2022 | 30789 | 0.020 |
Why?
| Leukocytes, Mononuclear | 1 | 2010 | 501 | 0.020 |
Why?
| Monocytes | 1 | 2010 | 507 | 0.020 |
Why?
| Membrane Proteins | 1 | 2012 | 1024 | 0.020 |
Why?
| Immunotherapy | 1 | 2010 | 479 | 0.020 |
Why?
| Cytokines | 1 | 2013 | 1853 | 0.020 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2017 | 2098 | 0.010 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2010 | 965 | 0.010 |
Why?
| Child | 1 | 2022 | 18503 | 0.010 |
Why?
| Macrophages | 1 | 2010 | 1284 | 0.010 |
Why?
|
|
Dobrinskikh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|